Depression and Anxiety Trial, Recruiting NCT06364488 Sponsor: BlueSkeye AI Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06364488
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who can speak and read English fluently
  • People who are able to give their own informed consent to participate
  • People who are at least 12 weeks pregnant, or who have given birth within the last 12 weeks
  • People who have access to the internet
  • People who have access to a compatible smartphone (for up to 10 participants who do not have their own device, the study team may be able to provide one)
  • People who have a current GP based within Nottinghamshire

Who may not be able to join:

  • People who currently have a clinically diagnosed psychiatric condition other than depression
  • People who have previously been diagnosed with a psychiatric condition other than depression or generalised anxiety disorder — this includes a history of psychosis, bipolar disorder, personality disorder, substance abuse disorders, or eating disorders
  • People who have a clinical diagnosis of autism spectrum disorder, attention deficit hyperactivity disorder (ADHD), Parkinson's disease, or any other current neurological condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Neil Nixon, MBBS, School of Medicine, University of Nottingham and Nottinghamshire Healthcare NHS Trust

Phone: 01689 856664

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
BlueSkeye AI
Registry
ClinicalTrials.gov
Start date
1 October 2024
Est. completion
31 July 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

The rate of device related adverse events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov